Loading...

What Does Knee Surgery Cost? Few Know, and That’s a Problem

By Melanie Evans / Aug. 21, 2018 For nearly a decade, Gundersen Health System’s hospital in La Crosse, Wis., boosted the price of knee-replacement surgery an average of 3% a year. By 2016, the average list price was more than $50,000, including the surgeon and anesthesiologist. Yet even as administrators raised the price, they had no real

By |2018-10-31T20:19:36+00:00October 31st, 2018|Recon|

Extremity Medical Announces the Release of the Omni Plating System

Parsippany, NJ – Oct 30, 2018 Extremity Medical, a global extremity implant company that provides innovative products for the upper and lower extremities, today announced the release of its newest implant system—the Omni Plating System. The Omni Plating System is designed to address a broad range of fusion procedures for the foot, and is integrated

By |2018-10-31T20:07:49+00:00October 31st, 2018|Extremities|

Alphatec Announces Participation at Stifel 2018 Healthcare Conference

CARLSBAD, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced it will present at the Stifel 2018 Healthcare Conference on November 14, 2018, at 2:00

By |2018-10-31T17:32:36+00:00October 31st, 2018|Spine|

Integra LifeSciences Reports Third Quarter 2018 Financial Results

PLAINSBORO, N.J., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2018. Third Quarter 2018 Consolidated Results Reported revenue was $365.9 million, an increase of 31.2% compared to the third quarter of 2017 with the acquisition of Codman

By |2018-10-31T17:17:16+00:00October 31st, 2018|Financial|

Amedica Announces Corporate Name Change to SINTX Technologies, Inc.

SALT LAKE CITY, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced that it has changed its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and robust pipeline of silicon nitride

By |2018-10-31T17:04:11+00:00October 31st, 2018|Biologics, Top Stories|

Stryker reports third quarter 2018 operating results

Kalamazoo, Michigan - October 25, 2018 - Stryker (NYSE:SYK) reported operating results for the third quarter of 2018: Third Quarter Highlights 2018 Net Sales Growth Overview Reported Excluding ASC 606 Adoption(2) Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 3.4 % 4.0 % (1.0 )% 5.0 % - % 5.0 % MedSurg 8.0 9.5 (0.9 ) 10.4 1.6 8.8

By |2018-10-30T22:51:45+00:00October 30th, 2018|Financial|

Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers

PARSIPPANY, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has announced that they will reimburse select ambulatory surgical centers (ASCs) for the use of EXPAREL® (bupivacaine liposome injectable suspension) as part of a pilot program in Florida and New Jersey. The purpose of the program is to incentivize the use of non-opioid therapies for postsurgical pain

By |2018-10-30T22:38:04+00:00October 30th, 2018|Regulatory|

Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada

COLUMBIA, Md., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, will present advanced clinical and scientific research at the Symposium on Advanced Wound Care (SAWC) Fall Conference. A total of six studies (three clinical and

By |2018-10-30T21:43:25+00:00October 30th, 2018|Biologics|

Bone Grafts and Substitutes Market is expected to surpass the value of US$ 3.9 bn by 2026, Says TMR

October 30, 2018 Albany, New York, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report titled ‘Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global bone grafts and substitutes market was valued at US$ 2.7 Bn in

By |2018-10-30T21:24:25+00:00October 30th, 2018|Financial|

NuVasive Reports Third Quarter 2018 Financial Results

SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended September 30, 2018. Third Quarter 2018 Highlights Revenue increased 9.8% to $271.3 million, or 10.2% on a constant currency basis; GAAP operating profit margin of 6.6%; Non-GAAP

By |2018-10-30T20:46:08+00:00October 30th, 2018|Financial|